Disc Medicine prices $225.5M upsized public offering of common stock and pre-funded warrants

Disc Medicine, Inc.

Offering of 3,918,182 shares at $55.00/share and 181,818 pre-funded warrants at $54.9999 each.
Gross proceeds ~$225.5M; net proceeds ~$243.3M after underwriters' option exercised in full.
Proceeds to fund clinical development, potential commercialization of bitopertin for EPP and XLP, and working capital.
Cash, equivalents, and marketable securities plus offering net proceeds expected to fund operations into 2028.
Offering closed January 24, 2025; underwriters include Jefferies, Leerink, Stifel, Cantor.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.